Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?

BACKGROUND: During illness, adaptations of the hypothalamic–pituitary‐thyroid axis reduce energy expenditure, protein catabolism and modulate immune responses to promote survival. Lower serum free triiodothyronine‐to‐thyroxine (fT3/fT4) ratio has been linked to non‐response to treatment in a range o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Simeng, Chanchlani, Neil, Carbery, Isabel, Janjua, Malik, Nice, Rachel, McDonald, Timothy J., Bewshea, Claire, Kennedy, Nicholas A., Ahmad, Tariq, Selinger, Christian P., Goodhand, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Thyroid Function Tests and Failure of Anti‐tnf Agents in Crohn's Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540440/
https://www.ncbi.nlm.nih.gov/pubmed/35768996
http://dx.doi.org/10.1111/apt.17089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540440/
https://www.ncbi.nlm.nih.gov/pubmed/35768996
http://dx.doi.org/10.1111/apt.17089

Ejemplares similares